| Vol. 6.28 – 16 August, 2021 |
| |
|
|
| Researchers reported that the miR-106b~25 cluster was higher expressed in the early postnatal myocardium and decreased in expression towards adulthood, especially under conditions of overload, and orchestrated the transition of cardiomyocyte hyperplasia towards cell cycle arrest and hypertrophy by virtue of its targetome. [Nature Communications] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| By multiple in vitro studies, the rhACE2 patch demonstrated effectiveness in reducing cardiomyocyte apoptosis under hypoxia stress and inhibiting cardiac fibroblasts proliferation, which gave evidence for its in vivo efficacy. [NPJ Regenerative Medicine] |
|
|
|
| Transcriptome analysis showed that genes related to fatty acid metabolism were dramatically downregulated, but genes critical for glycolysis were markedly upregulated in PparaΔCM hearts. [Acta Pharmacologica Sinica] |
|
|
|
| Researchers performed a comprehensive analysis of the transcriptional changes occurring during human iPSC (hiPSC) differentiation to cardiomyocytes. Using single cell RNA-seq, they sequenced > 20,000 single cells from 55 independent samples representing two differentiation protocols and multiple hiPSC lines. [Scientific Reports] |
|
|
|
| To investigate the role of carbonic anhydrase III in the apoptosis of myocytes under hypoxic conditions and facilitate the strategy for treating hypoxia-induced damage, in vitro experiments in H9c2 were employed. [Cardiovascular Toxicology] |
| |
|
|
| Investigators showed that SESTRIN1,2 loss resulted in hyperactivation of the mTORC1 complex, increased propensity to enter the cell cycle, and shifted in metabolic flux. Aged SESTRIN1,2 knockout mice exhibited loss of muscle stem cells and a reduced ability to regenerate injured muscle. [Stem Cell Reports] |
|
|
|
| Researchers found that specific inhibition of MyD88 reduced the activation of canonical nuclear factor-kappa pathway and expression of receptors for inflammatory cytokines in denervated muscle. [FASEB Journal] |
|
|
|
| | Scientists demonstrated cyclic compression of primary human endothelial cells, fibroblasts, and smooth muscle cells to show physiological changes in their morphology due to applied forces. [Scientific Reports] |
|
|
|
| Researchers examined the effects of Stmn2 on phenotype transformation of vascular smooth muscle in vascular injury via RNA sequencing and experimental validation. [Environmental Science and Pollution Research] |
|
|
|
| Human vascular smooth muscle cells were loaded with cholesterol and different concentrations of metformin. The expression levels of adhesion molecules were assessed via reverse transcription‑quantitative PCR and western blotting. [Molecular Medicine Reports] |
|
|
|
| Scientists elucidated the functions of miR‑125a‑5p and miR‑7 in vascular smooth muscle cells and investigated the associated molecular mechanisms. [Molecular Medicine Reports] |
| |
|
|
|
| Skeletal muscle atrophy is characterized by weakening, shrinking, and decreasing muscle mass and fiber cross-sectional area at the histological level. The authors review the mechanisms and treatment strategies for skeletal muscle atrophy. [Pharmacological Research] |
|
|
|
|
| Edgewise Therapeutics, Inc. announced that the US FDA has granted Fast Track designation for EDG-5506 for the treatment of individuals with BMD. EDG-5506, a selective, small molecule myosin inhibitor designed to protect injury-susceptible fast skeletal muscle fibers in DMD and BMD, is advancing in a Phase I clinical trial. [Edgewise Therapeutics, Inc.] |
|
|
|
|
| October 27 – 29, 2021 Virtual |
|
|
|
|
|
| The University of Tennessee Health Science Center – Memphis, Tennessee, United States |
|
|
|
| Buck Institute for Research on Aging – Novato, California, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| Weill Cornell Medicine – New York, New York, United States |
|
|
|
| The Scripps Research Institute – La Jolla, California, United States |
|
|
|
|